maaf email atau password anda salah

The Hunt for a Remedy

Tuesday, February 18, 2020

Doctors are testing various drugs to treat patients infected with the Covid-19 virus. Eijkman and Bio Farma are exploring vaccine development.

arsip tempo : 172167046516.

Coronavirus patients in Wuhan, February 6./ China Daily via REUTERS. tempo : 172167046516.

HUNDREDS of health experts from all over the world gathered at the World Health Organization (WHO) headquarters in Geneva, Switzerland, in mid-February. They discussed ways to address the Covid-19 virus, more popularly known as the coronavirus, which is currently plaguing China. “We must unite against this enemy,” said WHO Director-General Tedros Adhanom Ghebreyesus, as quoted on the WHO website on Wednesday, February 12.

Over 300 he


Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

More Articles

  • Tempo English Tuesday, February 18, 2020

  • Tempo English Tuesday, February 18, 2020

  • Tempo English Tuesday, February 18, 2020

  • Tempo English Tuesday, February 18, 2020

More exclusive contents

  • July 22, 2024

  • July 15, 2024

  • July 8, 2024

  • July 1, 2024

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe